{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:04:27Z","timestamp":1789833867511,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100019273","name":"National Institute for Medical Research","doi-asserted-by":"publisher","award":["IR.NIMAD.REC.1399.066"],"award-info":[{"award-number":["IR.NIMAD.REC.1399.066"]}],"id":[{"id":"10.13039\/501100019273","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Phospholipase-associated neurodegeneration (PLAN) caused by mutations in the\n                      <jats:italic>PLA2G6<\/jats:italic>\n                      gene is a rare neurodegenerative disorder that presents with four sub-groups. Infantile neuroaxonal dystrophy (INAD) and\n                      <jats:italic>PLA2G6<\/jats:italic>\n                      -related dystonia-parkinsonism are the main two subtypes. In this cohort, we reviewed clinical, imaging, and genetic features of 25 adult and pediatric patients harboring variants in the\n                      <jats:italic>PLA2G6<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      An extensive review of the patients\u2019 data was carried out. Infantile Neuroaxonal Dystrophy Rating Scale (INAD-RS) was used for evaluating the severity and progression of INAD patients. Whole-exome sequencing was used to determine the disease's underlying etiology followed by co-segregation analysis using Sanger sequencing. In silico prediction analysis based on the ACMG recommendation was used to assess the pathogenicity of genetic variants. We aimed to survey a genotype-genotype correlation in\n                      <jats:italic>PLA2G6<\/jats:italic>\n                      considering all reported disease-causing variants in addition to our patients using the HGMD database and the chi-square statistical approach.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eighteen cases of INAD and 7 cases of late-onset PLAN were enrolled. Among 18 patients with INAD, gross motor regression was the most common presenting symptom. Considering the INAD-RS total score, the mean rate of progression was 0.58 points per month of symptoms (Standard error 0.22, lower 95% \u2212\u20091.10, and upper 95% \u2212\u20090.15). Sixty percent of the maximum potential loss in the INAD-RS had occurred within 60\u00a0months of symptom onset in INAD patients. Among seven adult cases of PLAN, hypokinesia, tremor, ataxic gate, and cognitive impairment were the most frequent clinical features. Various brain imaging abnormalities were also observed in 26 imaging series of these patients with cerebellar atrophy being the most common finding in more than 50%. Twenty unique variants in 25 patients with PLAN were detected including nine novel variants. Altogether, 107 distinct disease-causing variants from 87 patient were analyzed to establish a genotype\u2013phenotype correlation. The P value of the chi-square test did not indicate a significant relationship between age of disease onset and the distribution of reported variants on\n                      <jats:italic>PLA2G6<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PLAN presents with a wide spectrum of clinical symptoms from infancy to adulthood. PLAN should be considered in adult patients with parkinsonism or cognition decline. Based on the current knowledge, it is not possible to foresee the age of disease onset based on the identified genotype.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-023-02780-9","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T22:02:02Z","timestamp":1688508122000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Phenotype and genotype heterogeneity of PLA2G6-associated neurodegeneration in a cohort of pediatric and adult patients"],"prefix":"10.1186","volume":"18","author":[{"given":"Ali Zare","family":"Dehnavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Bemanalizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyyed Mohammad","family":"Kahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud Reza","family":"Ashrafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Rohani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehran Beiraghi","family":"Toosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sareh","family":"Hosseinpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnam","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaghayegh","family":"Zokaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajar","family":"Aryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Amanat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Vahidnezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pouria","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Garshasbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0440-5809","authenticated-orcid":false,"given":"Ali Reza","family":"Tavasoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"issue":"9","key":"2780_CR1","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1523\/JNEUROSCI.4354-07.2008","volume":"28","author":"K Shinzawa","year":"2008","unstructured":"Shinzawa K, et al. Neuroaxonal dystrophy caused by group VIA phospholipase A2 deficiency in mice: a model of human neurodegenerative disease. J Neurosci. 2008;28(9):2212\u201320.","journal-title":"J Neurosci"},{"issue":"2","key":"2780_CR2","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1046\/j.1432-1327.1999.00418.x","volume":"262","author":"PK Larsson Forsell","year":"1999","unstructured":"Larsson Forsell PK, Kennedy BP, Claesson HE. The human calcium-independent phospholipase A2 gene: multiple enzymes with distinct properties from a single gene. Eur J Biochem. 1999;262(2):575\u201385.","journal-title":"Eur J Biochem"},{"issue":"9","key":"2780_CR3","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.cellsig.2005.03.002","volume":"17","author":"J Balsinde","year":"2005","unstructured":"Balsinde J, Balboa MA. Cellular regulation and proposed biological functions of group VIA calcium-independent phospholipase A2 in activated cells. Cell Signal. 2005;17(9):1052\u201362.","journal-title":"Cell Signal"},{"key":"2780_CR4","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.3389\/fneur.2018.01100","volume":"9","author":"Y-P Guo","year":"2018","unstructured":"Guo Y-P, Tang B-S, Guo J-F. PLA2G6-associated neurodegeneration (PLAN): review of clinical phenotypes and genotypes. Front Neurol. 2018;9:1100.","journal-title":"Front Neurol"},{"issue":"7","key":"2780_CR5","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/ng1826","volume":"38","author":"NV Morgan","year":"2006","unstructured":"Morgan NV, et al. PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet. 2006;38(7):752\u20134.","journal-title":"Nat Genet"},{"issue":"18","key":"2780_CR6","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1212\/01.wnl.0000327094.67726.28","volume":"71","author":"A Gregory","year":"2008","unstructured":"Gregory A, et al. Neurodegeneration associated with genetic defects in phospholipase A2. Neurology. 2008;71(18):1402\u20139.","journal-title":"Neurology"},{"issue":"1","key":"2780_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/jmd2.12116","volume":"54","author":"D Adams","year":"2020","unstructured":"Adams D, et al. Treatment of infantile neuroaxonal dystrophy with RT001: a di-deuterated ethyl ester of linoleic acid: Report of two cases. JIMD Rep. 2020;54(1):54\u201360.","journal-title":"JIMD Rep"},{"key":"2780_CR8","doi-asserted-by":"publisher","first-page":"109068","DOI":"10.1016\/j.biopha.2019.109068","volume":"118","author":"Z-B Wang","year":"2019","unstructured":"Wang Z-B, et al. Neurodegeneration with brain iron accumulation: Insights into the mitochondria dysregulation. Biomed Pharmacother. 2019;118:109068.","journal-title":"Biomed Pharmacother"},{"key":"2780_CR9","volume-title":"PLA2G6-associated neurodegeneration, GeneReviews\u00ae","author":"A Gregory","year":"2017","unstructured":"Gregory A, et al. PLA2G6-associated neurodegeneration, GeneReviews\u00ae. University of Washington Seattle; 2017."},{"issue":"18","key":"2780_CR10","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1212\/01.wnl.0000310986.48286.8e","volume":"70","author":"M Kurian","year":"2008","unstructured":"Kurian M, et al. Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN). Neurology. 2008;70(18):1623\u20139.","journal-title":"Neurology"},{"issue":"5","key":"2780_CR11","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1086\/508572","volume":"79","author":"S Khateeb","year":"2006","unstructured":"Khateeb S, et al. PLA2G6 mutation underlies infantile neuroaxonal dystrophy. Am J Hum Genet. 2006;79(5):942\u20138.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"2780_CR12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1468-1331.2008.02397.x","volume":"16","author":"Y Wu","year":"2009","unstructured":"Wu Y, et al. Clinical study and PLA2G6 mutation screening analysis in Chinese patients with infantile neuroaxonal dystrophy. Eur J Neurol. 2009;16(2):240\u20135.","journal-title":"Eur J Neurol"},{"issue":"6","key":"2780_CR13","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ejpn.2008.01.005","volume":"12","author":"I Carrilho","year":"2008","unstructured":"Carrilho I, et al. Infantile neuroaxonal dystrophy: what\u2019s most important for the diagnosis? Eur J Paediatr Neurol. 2008;12(6):491\u2013500.","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"2780_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1136\/jmg.2008.061929","volume":"46","author":"A Gregory","year":"2009","unstructured":"Gregory A, Polster BJ, Hayflick SJ. Clinical and genetic delineation of neurodegeneration with brain iron accumulation. J Med Genet. 2009;46(2):73\u201380.","journal-title":"J Med Genet"},{"issue":"1","key":"2780_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-020-01479-5","volume":"15","author":"PS Atwal","year":"2020","unstructured":"Atwal PS, et al. The infantile neuroaxonal dystrophy rating scale (INAD-RS). Orphanet J Rare Dis. 2020;15(1):1\u20139.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2780_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13023-020-01355-2","volume":"15","author":"FD Altuame","year":"2020","unstructured":"Altuame FD, et al. The natural history of infantile neuroaxonal dystrophy. Orphanet J Rare Dis. 2020;15(1):109.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2780_CR17","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.braindev.2014.04.010","volume":"37","author":"D Frattini","year":"2015","unstructured":"Frattini D, et al. Downbeat nystagmus as the presenting symptom of infantile neuroaxonal dystrophy: a case report. Brain Dev. 2015;37(2):270\u20132.","journal-title":"Brain Dev"},{"issue":"7","key":"2780_CR18","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1212\/WNL.52.7.1472","volume":"52","author":"N Nardocci","year":"1999","unstructured":"Nardocci N, et al. Infantile neuroaxonal dystrophy: clinical spectrum and diagnostic criteria. Neurology. 1999;52(7):1472\u20131472.","journal-title":"Neurology"},{"key":"2780_CR19","unstructured":"Purushothaman VV, Kumar DJ, Sankaran BP. Audiological findings in Children with PLA2G6-associated neurodegeneration. J Am Acad Audiol. 2022(AAM)."},{"issue":"3","key":"2780_CR20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1055\/s-2008-1052474","volume":"18","author":"VT Ramaekers","year":"1987","unstructured":"Ramaekers VT, et al. Diagnostic difficulties in infantile neuroaxonal dystrophy. A clinicopathological study of eight cases. Neuropediatrics. 1987;18(3):170\u20135.","journal-title":"Neuropediatrics"},{"issue":"10","key":"2780_CR21","doi-asserted-by":"publisher","first-page":"e76831","DOI":"10.1371\/journal.pone.0076831","volume":"8","author":"MA Salih","year":"2013","unstructured":"Salih MA, et al. New findings in a global approach to dissect the whole phenotype of PLA2G6 gene mutations. PLoS ONE. 2013;8(10):e76831.","journal-title":"PLoS ONE"},{"issue":"5","key":"2780_CR22","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s002340050768","volume":"41","author":"L Farina","year":"1999","unstructured":"Farina L, et al. Infantile neuroaxonal dystrophy: neuroradiological studies in 11 patients. Neuroradiology. 1999;41(5):376\u201380.","journal-title":"Neuroradiology"},{"issue":"5","key":"2780_CR23","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s12098-014-1608-z","volume":"82","author":"M Goyal","year":"2015","unstructured":"Goyal M, et al. Molecular diagnosis of infantile Neuro axonal Dystrophy by Next Generation Sequencing. Indian J Pediatr. 2015;82(5):474\u20137.","journal-title":"Indian J Pediatr"},{"issue":"4","key":"2780_CR24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1177\/104063879300500414","volume":"5","author":"KP Carmichael","year":"1993","unstructured":"Carmichael KP, et al. Neuroaxonal dystrophy in a group of related cats. J Vet Diagn Investig. 1993;5(4):585\u201390.","journal-title":"J Vet Diagn Investig"},{"issue":"5","key":"2780_CR25","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1177\/0300985817712557","volume":"54","author":"S Degl'Innocenti","year":"2017","unstructured":"Degl\u2019Innocenti S, et al. Neuroaxonal dystrophy and cavitating leukoencephalopathy of chihuahua dogs. Vet Pathol. 2017;54(5):832\u20137.","journal-title":"Vet Pathol"},{"issue":"3\u20134","key":"2780_CR26","first-page":"271","volume":"30","author":"A Taraszewska","year":"1992","unstructured":"Taraszewska A, Zelman IB. Ultrastructural pattern of brain aging in normal rabbit and in pt mutant. Neuropatol Pol. 1992;30(3\u20134):271\u201383.","journal-title":"Neuropatol Pol"},{"issue":"1","key":"2780_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-020-01355-2","volume":"15","author":"FD Altuame","year":"2020","unstructured":"Altuame FD, et al. The natural history of infantile neuroaxonal dystrophy. Orphanet J Rare Dis. 2020;15(1):1\u201312.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"2780_CR28","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.ajhg.2018.02.018","volume":"102","author":"PR Blackburn","year":"2018","unstructured":"Blackburn PR, et al. Bi-allelic alterations in AEBP1 lead to defective collagen assembly and connective tissue structure resulting in a variant of Ehlers-Danlos syndrome. Am J Hum Genet. 2018;102(4):696\u2013705.","journal-title":"Am J Hum Genet"},{"key":"2780_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ymgmr.2017.12.005","volume":"15","author":"AN Mohammad","year":"2018","unstructured":"Mohammad AN, et al. Type 1 sialidosis presenting with ataxia, seizures and myoclonus with no visual involvement. Mol Genet Metab Rep. 2018;15:11\u20134.","journal-title":"Mol Genet Metab Rep"},{"issue":"7","key":"2780_CR30","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1681\/ASN.2017111179","volume":"29","author":"M Reichold","year":"2018","unstructured":"Reichold M, et al. Glycine amidinotransferase (GATM), renal Fanconi syndrome, and kidney failure. J Am Soc Nephrol. 2018;29(7):1849\u201358.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2780_CR31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.braindev.2016.08.012","volume":"39","author":"A Iodice","year":"2017","unstructured":"Iodice A, et al. Infantile neuroaxonal dystrophy and PLA2G6-associated neurodegeneration: an update for the diagnosis. Brain Dev. 2017;39(2):93\u2013100.","journal-title":"Brain Dev"},{"issue":"1","key":"2780_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/ana.21415","volume":"65","author":"C Paisan-Ruiz","year":"2009","unstructured":"Paisan-Ruiz C, et al. Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Ann Neurol. 2009;65(1):19\u201323.","journal-title":"Ann Neurol"},{"key":"2780_CR33","doi-asserted-by":"crossref","unstructured":"Karkheiran S et al. PLA2G6-associated dystonia\u2013parkinsonism: case report and literature review 5;2015.","DOI":"10.5334\/tohm.254"},{"issue":"15","key":"2780_CR34","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1212\/WNL.0b013e3181f73649","volume":"75","author":"H Yoshino","year":"2010","unstructured":"Yoshino H, et al. Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism. Neurology. 2010;75(15):1356\u201361.","journal-title":"Neurology"},{"issue":"4","key":"2780_CR35","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.neurobiolaging.2010.05.009","volume":"33","author":"C Pais\u00e1n-Ruiz","year":"2012","unstructured":"Pais\u00e1n-Ruiz C, et al. Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. Neurobiol Aging. 2012;33(4):814\u201323.","journal-title":"Neurobiol Aging"},{"issue":"9","key":"2780_CR36","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1002\/mds.23617","volume":"26","author":"MA Bower","year":"2011","unstructured":"Bower MA, et al. Novel mutations in siblings with later-onset PLA2G6-associated neurodegeneration (PLAN). Mov Disord. 2011;26(9):1766\u20137.","journal-title":"Mov Disord"},{"issue":"2","key":"2780_CR37","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.parkreldis.2013.10.016","volume":"20","author":"T Virmani","year":"2014","unstructured":"Virmani T, et al. Oculogyric crises induced by levodopa in PLA2G6 parkinsonism-dystonia. Parkinsonism Relat Disord. 2014;20(2):245\u20137.","journal-title":"Parkinsonism Relat Disord"},{"issue":"13","key":"2780_CR38","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1002\/mds.25160","volume":"27","author":"P Agarwal","year":"2012","unstructured":"Agarwal P, et al. Imaging striatal dopaminergic function in phospholipase A2 group VI-related Parkinsonism. Mov Disord. 2012;27(13):1698\u20139.","journal-title":"Mov Disord"},{"issue":"2","key":"2780_CR39","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24(2):197\u2013211.","journal-title":"Neurobiol Aging"}],"updated-by":[{"DOI":"10.1186\/s13023-023-02794-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000}}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02780-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02780-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02780-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T17:01:48Z","timestamp":1689613308000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02780-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2780"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02780-9","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,5]]},"assertion":[{"value":"15 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13023-023-02794-3","URL":"https:\/\/doi.org\/10.1186\/s13023-023-02794-3","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics committee of Tehran University of Medical Sciences and the ethics committee of the National Institute for Medical Research Development (NIMAD) of Iran approved our study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was written by the parents of our patient to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"177"}}